Parliament and regulators
Genetic testing protections now apply to life insurance
A federal ban on soliciting or using protected genetic information in life-insurance underwriting has commenced.
Where it standsEnacted. Schedule 1 commenced on 8 October 2026 and applies to relevant life-insurance decisions from that date.
What happened
Life insurers now face a strict-liability offence and civil penalty if protected genetic information is solicited or used in underwriting that informs a life-insurance contract decision. The protection covers testing undertaken, intended or recommended, as well as test results for the insured or a genetic relative.
The law does not treat a clinically diagnosed disease, or ordinary information about its treatment and prognosis, as protected genetic information. Unsolicited information may be used only within a narrow exception requiring written consent and no disadvantage to the insured or beneficiary.
Why it matters
Insurance and dispute intake should separate genetic-test information from diagnosed conditions and capture whether information was requested, volunteered and used in a decision.
What a firm does with this
Lawgistics opportunity: add a dated genetic-information checkpoint to relevant intake and triage workflows, with escalation for decisions made from 8 October 2026.
Read the source
- Federal Register of Legislation: Act and commencement table
- Treasury Ministers: legislation passed and enforcement framework
General information, not legal advice. A summary is not the judgment, bill or release: read the source before you rely on it.